Cosmo Pharmaceuticals N.V. (LON:0RGI)

Cosmo Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 23, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	936	901	763	900	895	1,018
Market Cap Growth	-15.60%	18.10%	-15.23%	0.57%	-12.08%	16.39%
Enterprise Value	833	795	727	864	864	956
Last Close Price	58.51	54.21	44.95	50.96	47.90	63.34
PE Ratio	18.19	8.18	-	58.91	49.16	-
PS Ratio	5.99	4.08	9.48	9.94	16.37	18.64
PB Ratio	2.34	2.16	2.18	2.19	2.08	2.84
P/TBV Ratio	10.19	3.48	3.43	14.09	9.52	2.87
P/FCF Ratio	16.11	6.90	45.41	35.34	149.55	128.14
P/OCF Ratio	14.85	6.71	38.72	30.54	84.48	87.48
EV/Sales Ratio	5.24	3.60	9.03	9.54	15.80	17.50
EV/EBITDA Ratio	11.76	5.99	90.38	23.65	57.74	176.12
EV/EBIT Ratio	13.89	6.46	-	34.71	92.64	590.89
EV/FCF Ratio	14.35	6.09	43.26	33.92	144.35	120.31
Debt / Equity Ratio	0.01	0.00	0.01	0.37	0.33	0.42
Debt / EBITDA Ratio	0.03	0.01	0.18	4.14	9.20	24.49
Debt / FCF Ratio	0.04	0.01	0.10	6.05	23.85	18.97
Asset Turnover	0.29	0.46	0.14	0.13	0.09	0.10
Inventory Turnover	3.64	3.27	3.06	3.29	3.50	4.66
Quick Ratio	3.59	3.39	3.22	1.45	11.77	11.06
Current Ratio	3.84	4.19	4.07	1.57	12.99	11.60
Return on Equity (ROE)	12.34%	29.31%	-2.47%	3.58%	4.75%	-1.99%
Return on Assets (ROA)	6.88%	15.87%	-0.18%	2.24%	0.99%	0.19%
Return on Capital (ROIC)	8.80%	20.39%	-0.22%	2.66%	1.11%	0.20%
Return on Capital Employed (ROCE)	12.20%	24.90%	-	5.00%	1.40%	0.30%
Earnings Yield	5.50%	12.23%	-1.23%	1.70%	2.03%	-0.70%
FCF Yield	6.21%	14.49%	2.20%	2.83%	0.67%	0.78%
Dividend Yield	2.74%	3.13%	3.86%	1.83%	1.67%	-
Payout Ratio	94.36%	24.09%	-	90.61%	-	-
Buyback Yield / Dilution	-1.65%	-1.94%	1.95%	2.83%	-16.81%	1.11%
Total Shareholder Return	1.09%	1.19%	5.81%	4.66%	-15.15%	1.11%

Updated Jul 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.